
    
      Aims are to measure Macrophage Migration Inhibitory Factor, Macrophage Migration Inhibitory
      Factor II and its' soluble receptor CD74 in serum, liver graft effluent and urine in and
      evaluate MIF's role in hepatic ischemia/reperfusion injury, postoperative graft function and
      kidney function.
    
  